Qui Tam Basics

Federal and State False Claims Act


Facts You Should Know About Qui Tam



Tax Whistleblower Laws



Securities and Commodities Whistleblower Laws



Articles


Whistleblower Stories



Resources


Contact Us About a Potential Case



Home


Qui tam Whistleblowers
This site provides news and information about the False Claims Act qui tam whistleblower law, the Tax Whistleblower law and the Securities and Commodities Whistleblower law. On this site you can learn the basics of each law and the process of bringing a case as well as read about the latest developments.

Getnick & Getnick LLP is a Manhattan-based law firm dedicated to business integrity and anti-fraud cases. Our whistleblower cases have resulted in recoveries of over a billion dollars for U.S. taxpayers.
Daily Blog Search


Advanced Blog Search

Monthly Archives
Most recent entries
Syndicate

Wednesday, October 21, 2009

Mylan Inc Pays US Government $121 Million for Whistleblower Dispute Over Generic Drug Sales

Generic drug maker, Mylan Inc, will pay the U.S government $121 million to settle a civil dispute, started by a whistleblower, involving Medicaid rebates on drug sales from 2000 to 2004.

The dispute called into question whether an authorized generic medicine is subject to the generic rate that Mylan paid on sales from 2000 to 2004, or a higher innovator rate. Mylan was treating its authorized generics as traditional generics, a practice they began before government guidelines were put in place.

The whistleblower, Ven-A-Care, a pharmacy in Key West, Florida, will receive $10.8 million as its share of the recovery.

Posted by Qui Tam Admin on 10/21 at 02:08 PM
Permalink
Page 1 of 1 pages
Printer Friendly Printer Friendly Page
Disclaimer
This Site supported by Getnick & Getnick LLP Copyright © 2006

Designed, Developed and Maintained By Interactive Media Associates, Inc.